Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Researchers made two new compounds that could be used for medicine.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

The compounds tested could potentially treat hair loss and alopecia.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

A new method was developed to make finasteride for treating hair loss.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Human beard hair follicles change testosterone into other related hormones, but don't much change androstenedione into testosterone.

Beard hair follicles convert testosterone to 5α-dihydrotestosterone most intensively.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Caucasian men have more chest hair and higher levels of certain androgen products than Chinese men.

Sebocytes play a key role in controlling androgen levels in human skin.

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

The methods accurately measured brain androgens, showing most 5α-androstane-3α,17β-diol comes from outside the brain, while androsterone is both transported and made in the brain.

The method produces finasteride with a 92% yield.